MS drug study: Beware drug company press releases that are used to report drug trial results, and of course it has favourable results

Madely Health Headlines Commentary for March , 2013


Excellent Results For MS Drug “Plegridy”


The results were presented at the American Academy of Neurology’s 65th Annual Meeting. It is not published.

Further it compares the drug to placebo, a useless marker for clinicians. We want to know how it fares against other medication of a similar class at least and how it compares to other medication in use today.  It also refers to relative and not absolute risk reduction.